Your Shopping Cart Is Empty
| Report Code: A06209 | Apr 2020 | Pages: 289 | ||
| Tables: 151 | Charts: 53 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Life Science Analytics Software Market
Request Now !The global life science analytics software market size was $5.35 billion in 2019, and is expected to reach $16.04 billion by 2027 at a CAGR of 12.3% from 2020 to 2027.Analytical software executes statistical and quantitative analysis. It creates and exports predictive and exploratory models for decision making. Thus, the life science industry is adapting data analytics to make best possible decisions. This analytics software can be used in research and development, clinical trials, preclinical trials, sales and marketing support, pharmacovigilance and other purposes by different biotechnology firms, pharmaceutical companies, medical device enterprises, and other end users. This analytics tool overcomes challenges in operational efficiency and data integration, which helps life science companies to improve lives of their customers and maintain leadership in the market.
Further, such analytics capabilities improve the performance of pharmaceutical manufacturing so that they can deliver safe, effective drugs and other therapies to patients with greater efficiency and confidence. The key applications of analytics software in the life science industry include research & development, clinical trials, sales and marketing support, and regulatory compliance. The software helps to over come challenges in data integration and enhance operational efficiency. Moreover, the integration of artificial intelligence (AI) and machine learning approaches within the life science industry is making drug discovery and development more innovative, time-effective, and cost-effective. Thus, these factors boostthe demand for life science analytics software market.
Growth of the global life science analytics software market is majorly driven by surge in prevalence of chronic diseases, pressure to reduce healthcare expenditure, and increased demand for improved patient outcomes. In addition, rise in adoption of analytics for sales and marketing applications and clinical trials further boosts the market growth. However, lack of skilled professionals and high implementation costshamper the market growth. On the contrary, emergence of big data analytics to increase R & D productivityare expected to provide significant profitable opportunities for manufacturers in the life science analytics software industry.
The life science analytics software market is segmented on the basis of product, application, delivery model, end user, and region. By product, it is divided into descriptive analytics, prescriptive analytics, and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics, and pharmacovigilance. The research & development is further segmented into clinical trials and preclinical trials. On the basis of delivery model, it is bifurcated into on-premise and cloud. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators (TPAS). Region wise, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.
By product, the descriptive analytics segment accounted for the largest life science analytics software market share in 2019. This was attributed to the significant useof descriptive analytics by life science stakeholders to gain a better understanding of past trends and events occurring in real-time.
On the basis of application, the sales & marketing segment is expected to grow at the highest CAGR during the forecast period. The is attributed to the rise in adoption of analytics by life science companies to align their sales & marketing campaigns. Surge in importance of post-marketing surveillance also propels the utilization of analytics for sales & marketing in the life science industry
North America held the major share of the life science analytics software market in 2019, and is expected to continue this dominance during the forecast period, owing to strong economies in the U.S. and Canada; high adoption rate of advanced technologies due to large number of investments to boost the life science industry; and presence of major players and their products across the region. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to the surge in prevalence of chronic diseases, growth of the life science industry, rise in adoption of advanced technologies, andgrowth in focus of major players on increasing their presence in emerging countries
Some of the key players operating in the life science analytics software market include Accenture Plc, ArisGlobal LLC, Chemical Abstracts Services(ACS), Certara, L.P., Clarivate Analytics Plc, Cognizant Technology Solutions Corporation, Dassault Systemes, Deloitte ToucheTohmatsu Limited, IQVIA Holdings Inc., Microsoft Corporation, Oracle Corporation, TIBCO Software Inc., andVeeva Systems Inc.
Key Benefits For Stakeholders
This report entails a detailed quantitative analysis along with the current global life science analytics software market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
The life science analytics software market forecast is studied from 2020 to 2027.
The market size and estimations are based on a comprehensive analysis of key developments in thelife science analytics software industry.
A qualitative life science analytics software market analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the life science analytics software market.
Life Science Analytics Software Market Report Highlights
| Aspects | Details |
|---|---|
| By PRODUCT |
|
| By APPLICATION |
|
| By DELIVERY MODEL |
|
| By END USER |
|
| By Region |
|
| Key Market Players | CLARIVATE ANALYTICS PLC, IQVIA HOLDINGS INC, CERTARA, L.P., ORACLE CORPORATION, ACCENTURE PLC, MICROSOFT CORPORATION, COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION, DELOITTE, DASSAULT SYSTEMES, CHEMICAL ABSTRACTS SERVICES (ACS), ARISGLOBAL LLC, TIBCO SOFTWARE INC, VEEVA SYSTEMS INC |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
1.4.4.Primary research
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.2.3.Top player positioning, 2019
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Surge in prevalence of chronic disease
3.4.1.2.Pressure to reduce healthcare expenditure & increased demand for improved patient outcomes.
3.4.1.3.Rise in adoption of analytics solutions in clinical trials and sales & marketing applications
3.4.2.Restraints
3.4.2.1.Lack of skilled professionals in developing countries
3.4.2.2.Data privacy issues
3.4.3.Opportunity
3.4.3.1.Emergence of big data analytics to increase R&D productivity
CHAPTER 4:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Descriptive analytics
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Predictive Analytics
4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Prescriptive analytics
4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Research and development
5.2.1.Market size and forecast, by type
5.2.1.1.Clinical Trials
5.2.1.1.1.Market size and forecast
5.2.1.2.Preclinical Trials
5.2.1.2.1.Market size and forecast
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Sales and marketing support
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Regulatory compliance
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Supply chain analytics
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Pharmacovigilance
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL
6.1.Overview
6.1.1.Market size and forecast
6.2.On-premise
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Cloud
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
CHAPTER 7:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Pharmaceutical and biotechnology companies
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.3.Medical device companies
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
7.4.Research centers
7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country
7.5.Third-party administrators
7.5.1.Market size and forecast, by region
7.5.2.Market analysis, by country
CHAPTER 8:LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors and opportunities
8.2.2.North America life science analytics software market, by country
8.2.2.1.U.S. life science analytics software market, by product
8.2.2.2.U.S life science analytics software market, by application
8.2.2.3.U.S. life science analytics software market, by delivery model
8.2.2.4.U.S. life science analytics software market, by end user
8.2.2.5.Canada life science analytics software market, by product
8.2.2.6.Canada life science analytics software market, by application
8.2.2.7.Canada life science analytics software market, by delivery model
8.2.2.8.Canada life science analytics software market, by end user
8.2.2.9.Mexico life science analytics software market, by product
8.2.2.10.Mexico life science analytics software market, by application
8.2.2.11.Mexico life science analytics software market, by delivery model
8.2.2.12.Mexico life science analytics software market, by end user
8.2.3.North America life science analytics software market, by product
8.2.4.North America life science analytics software market, by application
8.2.5.North America life science analytics software market, by delivery model
8.2.6.North America life science analytics software market, by end user
8.3.Europe
8.3.1.Key market trends, growth factors and opportunities
8.3.2.Europe life science analytics software market, by country
8.3.2.1.UK life science analytics software market, by product
8.3.2.2.UK life science analytics software market, by application
8.3.2.3.UK life science analytics software market, by delivery model
8.3.2.4.UK life science analytics software market, by end user
8.3.2.5.Germany life science analytics software market, by product
8.3.2.6.Germany life science analytics software market, by application
8.3.2.7.Germany life science analytics software market, by delivery model
8.3.2.8.Germany life science analytics software market, by end user
8.3.2.9.France life science analytics software market, by product
8.3.2.10.France life science analytics software market, by application
8.3.2.11.France life science analytics software market, by delivery model
8.3.2.12.France life science analytics software market, by end user
8.3.2.13.Italy life science analytics software market, by product
8.3.2.14.Italy life science analytics software market, by application
8.3.2.15.Italy life science analytics software market, by delivery model
8.3.2.16.Italy life science analytics software market, by end user
8.3.2.17.Spain life science analytics software market, by product
8.3.2.18.Spain life science analytics software market, by application
8.3.2.19.Spain life science analytics software market, by delivery model
8.3.2.20.Spain life science analytics software market, by end user
8.3.2.21.Rest of Europe life science analytics software market, by product
8.3.2.22.Rest of Europe life science analytics software market, by application
8.3.2.23.Rest of Europe life science analytics software market, by delivery model
8.3.2.24.Rest of Europe life science analytics software market, by end user
8.3.3.Europe life science analytics software market, by product
8.3.4.Europe life science analytics software market, by application
8.3.5.Europe life science analytics software market, by delivery model
8.3.6.Europe life science analytics software market, by end user
8.4.Asia-pacific
8.4.1.Key market trends, growth factors and opportunities
8.4.2.Asia-Pacific life science analytics software market, by country
8.4.2.1.Japan life science analytics software market, by product
8.4.2.2.Japan life science analytics software market, by application
8.4.2.3.Japan life science analytics software market, by delivery model
8.4.2.4.Japan life science analytics software market, by end user
8.4.2.5.China life science analytics software market, by product
8.4.2.6.China life science analytics software market, by application
8.4.2.7.China life science analytics software market, by delivery model
8.4.2.8.China life science analytics software market, by end user
8.4.2.9.Australia life science analytics software market, by product
8.4.2.10.Australia life science analytics software market, by application
8.4.2.11.Australia life science analytics software market, by delivery model.
8.4.2.12.Australia life science analytics software market, by end user
8.4.2.13.India life science analytics software market, by product
8.4.2.14.India life science analytics software market, by application
8.4.2.15.India life science analytics software market, by delivery model
8.4.2.16.India life science analytics software market, by end user
8.4.2.17.Rest of Asia-Pacific life science analytics software market, by product
8.4.2.18.Rest of Asia-Pacific life science analytics software market, by application
8.4.2.19.Rest of Asia-Pacific life science analytics software market, by delivery model
8.4.2.20.Rest of Asia-Pacific life science analytics software market, by end user
8.4.3.Asia-Pacific life science analytics software market, by product
8.4.4.Asia-Pacific life science analytics software market, by application
8.4.5.Asia-Pacific life science analytics software market, by delivery model
8.4.6.Asia-Pacific life science analytics software market, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors and opportunities
8.5.2.LAMEA life science analytics software market, by country
8.5.2.1.Brazil life science analytics software market, by product
8.5.2.2.Brazil life science analytics software market, by application
8.5.2.3.Brazil life science analytics software market, by delivery model
8.5.2.4.Brazil life science analytics software market, by end user
8.5.2.5.Saudi Arabia life science analytics software market, by product
8.5.2.6.Saudi Arabia life science analytics software market, by application
8.5.2.7.Saudi Arabia life science analytics software market, by delivery model
8.5.2.8.Saudi Arabia life science analytics software market, by end user
8.5.2.9.South Africa life science analytics software market, by product
8.5.2.10.South Africa life science analytics software market, by application
8.5.2.11.South Africa life science analytics software market, by delivery model
8.5.2.12.South Africa life science analytics software market, by end user
8.5.2.13.Rest of LAMEA life science analytics software market, by product
8.5.2.14.Rest of LAMEA life science analytics software market, by application
8.5.2.15.Rest of LAMEA life science analytics software market, by delivery model
8.5.2.16.Rest of LAMEA life science analytics software market, by end user
8.5.3.LAMEA life science analytics software market, by product
8.5.4.LAMEA life science analytics software market, by application
8.5.5.LAMEA life science analytics software market, by delivery model
8.5.6.LAMEA life science analytics software market, by end user
CHAPTER 9:COMPANY PROFILES
9.1.ACCENTURE PLC
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.ARISGLOBAL LLC
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Key strategic moves and developments
9.3.CHEMICAL ABSTRACTS SERVICES (ACS)
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.4.CERTARA, L.P.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Key strategic moves and developments
9.5.CLARIVATE ANALYTICS PLC
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments
9.6.COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.DASSAULT SYSTEMES
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments:
9.7.4.Product portfolio
9.7.5.Business performance
9.8.DELOITTE
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.IQVIA HOLDINGS INC
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.MICROSOFT CORPORATION
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.11.ORACLE CORPORATION
9.11.1.Company overview
9.11.2.Company snapshot
9.11.3.Operating business segments
9.11.4.Product portfolio
9.11.5.Business performance
9.11.6.Key strategic moves and developments
9.12.TIBCO SOFTWARE INC
9.12.1.Company overview
9.12.2.Operating business segments
9.12.3.Product portfolio
9.13.VEEVA SYSTEMS INC
9.13.1.Company overview
9.13.2.Company snapshot
9.13.3.Operating business segments
9.13.4.Product portfolio
9.13.5.Business performance
LIST OF TABLES
TABLE 01.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FORPRESCRIPTIVE ANALYTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 06.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR RESEARCH AND DEVELOPMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR SALES AND MARKETING SUPPORT, BY REGION, 2019–2027 ($MILLION)
TABLE 09.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR REGULATORY COMPLIANCE, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR PHARMACOVIGILANCE, BY REGION, 2019–2027 ($MILLION)
TABLE 12.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027($MILLION)
TABLE 13.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR ON-PREMISE, BY REGION, 2019–2027 ($MILLION)
TABLE 14.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR CLOUD, BY REGION, 2019–2027 ($MILLION)
TABLE 15.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 16.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2027 ($MILLION)
TABLE 17.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019–2027 ($MILLION)
TABLE 18.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR RESEARCH CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2019–2027 ($MILLION)
TABLE 20.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 21.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 22.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 23.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 25.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 26.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 27.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 28.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 29.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 30.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 31.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 32.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 33.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 34.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 35.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 36.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 37.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 38.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 39.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 40.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 42.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 43.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 44.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 45.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 46.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 47.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 48.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 49.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 50.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 51.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 52.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 53.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 54.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 55.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 56.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 57.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 58.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 59.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 60.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 62.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 63.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 64.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 65.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 66.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 67.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 68.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 69.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 70.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 71.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 72.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 73.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 74.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 75.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 76.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 77.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 78.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 79.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 80.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 81.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 82.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 83.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 84.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 85.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 86.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 87.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 88.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 89.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 90.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 91.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 92.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 93.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 94.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 95.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 96.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 97.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 98.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 99.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 100.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 101.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 102.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 103.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 104.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 105.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 106.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 107.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 108.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 109.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 110.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 111.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)
TABLE 112.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 113.ACCENTURE: COMPANY SNAPSHOT
TABLE 114.: PRODUCT SEGMENTS
TABLE 115.ACCENTURE: PRODUCT PORTFOLIO
TABLE 116.ARISGLOBAL: COMPANY SNAPSHOT
TABLE 117.ARISGLOBAL: OPERATING SEGMENTS
TABLE 118.ARISGLOBAL: PRODUCT PORTFOLIO
TABLE 119.CAS/ACS: COMPANY SNAPSHOT
TABLE 120.CAS/ACS: OPERATING SEGMENTS
TABLE 121.CAS/ACS: PRODUCT PORTFOLIO
TABLE 122.CERTARA: COMPANY SNAPSHOT
TABLE 123.CERTARA: OPERATING SEGMENTS
TABLE 124.CERTARA: PRODUCT PORTFOLIO
TABLE 125.CLARIVATE: COMPANY SNAPSHOT
TABLE 126.CLARIVATE: OPERATING BUSINESS SEGMENTS
TABLE 127.CLARIVATE: PRODUCT PORTFOLIO
TABLE 128.COGNIZANT: COMPANY SNAPSHOT
TABLE 129.COGNIZANT: OPERATING BUSINESS SEGMENTS
TABLE 130.COGNIZANT: PRODUCT PORTFOLIO
TABLE 131.DASSAULT: COMPANY SNAPSHOT
TABLE 132.DASSAULT: OPERATING BUSINESS SEGMENTS
TABLE 133.DASSAULT: PRODUCT PORTFOLIO
TABLE 134.DELOITTE: COMPANY SNAPSHOT
TABLE 135.DELOITTE: OPERATING SEGMENTS
TABLE 136.DELOITTE: PRODUCT PORTFOLIO
TABLE 137.IQVIA: COMPANY SNAPSHOT
TABLE 138.IQVIA: OPERATING SEGMENTS
TABLE 139.IQVIA: PRODUCT PORTFOLIO
TABLE 140.MICROSOFT: COMPANY SNAPSHOT
TABLE 141.MICROSOFT: OPERATING SEGMENTS
TABLE 142.MICROSOFT: PRODUCT PORTFOLIO
TABLE 143.ORACLE: COMPANY SNAPSHOT
TABLE 144.ORACLE: OPERATING SEGMENTS
TABLE 145.ORACLE: PRODUCT PORTFOLIO
TABLE 146.TIBCO: COMPANY SNAPSHOT
TABLE 147.TIBCO: OPERATING SEGMENTS
TABLE 148.TIBCO: PRODUCT PORTFOLIO
TABLE 149.VEEVA: COMPANY SNAPSHOT
TABLE 150.VEEVA: OPERATING SEGMENTS
TABLE 151.VEEVA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.LIFE SCIENCE ANALYTICS SOFTWARE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS IN LIFE SCIENCE ANALYTICS SOFTWARES MARKET, 2019
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020*
FIGURE 06.TOP PLAYER POSITIONING, 2019
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH BARGAINING POWER OF BUYERS
FIGURE 09.LOW THREAT OF SUBSTITUTIONS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.MODERATE COMPETITIVE RIVALRYS
FIGURE 12.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE: RESTRAINTS, DRIVERS AND OPPORTUNITY
FIGURE 13.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR DESCRIPTIVE ANALYTICS BY COUNTRY, 2019 & 2027(%)
FIGURE 14.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR PREDICTIVE ANALYTICS BY COUNTRY, 2019 &2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR PRESCRIPTIVEANALYTICS BY COUNTRY, 2019 &2027 (%)
FIGURE 16.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY CLINICAL TRIAL, 2019–2027 ($MILLION)
FIGURE 17.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY PRECLINICAL TRIALS, 2019–2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SALES AND MARKETING SUPPORT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SUPPLY CHAIN ANALYTICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR ON-PREMISE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR CLOUD, BY COUNTRY, 2019 & 2027 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 26.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET, FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 27.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RSEARCH CENTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 28.COMPARATIVE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 29.ACCENTURE: NET SALES, 2016–2018 ($MILLION)
FIGURE 30.ACCENTURE: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 31.ACCENTURE: REVENUE SHARE, BY REGION, 2018(%)
FIGURE 32.CLARIVATE: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.CLARIVATE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 34.CLARIVATE: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 35.COGNIZANT: NET SALES, 2016–2018 ($MILLION)
FIGURE 36.COGNIZANT: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 37.COGNIZANT: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 38.DASSAULT: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.DASSAULT: REVENUE SHARE, BYREGION 2019 (%)
FIGURE 40.DELOITTE: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.DELOITTE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.IQVIA: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.IQVIA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 44.IQVIA: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 45.MICROSOFT: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.MICROSOFT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.MICROSOFT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 48.ORACLE: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.ORACLE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.ORACLE: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 51.VEEVA: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.VEEVA: REVENUE SHARE, BY PRODUCT, 2020 (%)
FIGURE 53.VEEVA: REVENUE SHARE, BY REGION, 2020(%)
In the field of life science analytics software is still young and has gained significant attention over past few years. The life science analytics software market has piqued the interest of pharmaceutical, biotechnology and medical device companies as well as research centers, owing to several benefits offered by this software to reduce healthcare expenditure, improve patient outcomes and manage sales & marketing and supply chain. There have been remarkable technological advancements in the development of novel drugs and life science analytics software applications provide advanced data management options and improves R & D productivity. As the market is growing at a constant rate in developed nations, Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players in this market.
Moreover, big data in the life science industry is projected to increase the adoption rate of life science analytics software globally. Presently, growth in adoption of these software is witnessed in developing economies for development of novel drugs and to increase R & D efficiency, clinical trials and preclinical trials.
A. The market value of global Life Science Analytics market was $5,360 million in 2019.
A. The forecast period is from 2020 to 2027.
A. The market value of global Life Science Analytics market in 2020 is $6,188 million.
A. the adoption of big data in Life Science industry and growing Adoption of Analytics Solutions in Clinical Trials is expected to increase due to rise in incidence of chronic diseases. This would help researchers to take better decision.
A. The base year is 2019 in Life Science Analytics market
A. Increasing focus on value-based medicine and use of analytics in precision and personalized medicine
A. The North America market held a major share in the Life Science Analytics market in 2018 and is expected to continue the trend in the forecasting period, owing to strong economies in the U.S. and Canada; high adoption rate of advanced technologies, attributed to a large number of investments to boost the life science industry; and presence of major players and their products across the region.
Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report